At-Home STI Tests for Women: Panels, Specimen Sites, Labs, and Limits

Start with the infections and sites, not the size of the panel

An at-home sexually transmitted infection test can be useful, but no single kit answers every sexual-health question. Compare the infections it detects, the body site it samples, who it is intended for, and what happens after the result. CDC distinguishes testing done entirely at home from collecting a sample at home and sending it to a laboratory. Which tests you need depends on factors such as symptoms, sexual practices, exposure, and medical history. 1

A vaginal sample is not a throat or rectal sample. Someone concerned about infection after oral or anal sex may need different testing even if a vaginal result is negative. Discuss those exposures rather than assuming that a product labeled “for women” covers every relevant site. 1

This U.S.-focused comparison was checked on September 14, 2026. The examples below illustrate FDA-authorized testing models; they are not an exhaustive market list, a stock check, or a ranking of the best products.

Two different meanings of “at home”

A device that produces results at home

FDA authorized the Visby Medical Women's Sexual Health Test in March 2025. It uses a self-collected vaginal swab to test for chlamydia, gonorrhea, and trichomoniasis, with results available in about 30 minutes through an app connected to the single-use device. The authorization covers over-the-counter use by females with or without symptoms. 2

The practical distinction is that the sample is analyzed in the home device rather than mailed to a laboratory. Before purchasing, check the current instructions, phone and app requirements, intended population, and access to follow-up care. FDA authorization does not establish that a particular retailer has the product in stock today. 2

A collection kit sent to a laboratory

FDA authorized the LetsGetChecked Simple 2 home-collection system in November 2023 for adults aged 18 and older. It tests for chlamydia and gonorrhea, using the vaginal-swab or urine kit specified for the intended user and sample. Users activate the kit online, complete a health questionnaire, and send the sample to the designated laboratory; results are delivered online, with healthcare-provider follow-up for positive or invalid results. 3

This is not an instant home result. Collection, shipping, laboratory processing, and notification are separate steps. The authorization ties the collection system to a specific cleared laboratory assay. It is not permission to combine any swab, mailing tube, and commercial testing panel. 3

The difference between these examples is not merely speed: one includes trichomoniasis and the other does not. Compare the actual target list, not a broad phrase such as “sexual health panel.” 2 3

A bigger panel is not automatically the right panel

Write down what you need to know before comparing packages. Does the kit test for the infection you are concerned about? Does it use the appropriate sample? Does the intended-use information match your circumstances? CDC's testing guidance includes blood, urine, vaginal, throat, and rectal samples, depending on the question. 1

Neither of the two panels above is a complete investigation of vaginal itching. A test limited to the named STIs does not, by itself, establish whether symptoms come from yeast, bacterial vaginosis, irritation, or a vulvar skin condition. Its negative result is limited to its targets and testing conditions, not a declaration that all possible causes have been excluded. 1 2 3

For the clinical comparison, see yeast infection versus STI symptoms. For the specimen question, see why vaginal, urine, throat, and rectal samples are not interchangeable.

Questions worth answering before payment

Use the product label and service terms to answer four questions:

• What exactly is included? List the infections, sample site, kit type, and whether the price includes laboratory processing.
• What does the quoted timing measure? Device run time, delivery time, and processing after sample arrival are not the same promise.
• Who handles an invalid or positive result? Ask about replacement samples, clinical contact, treatment or referral, and any additional charge.
• Who holds the record? Identify the testing service, performing laboratory where applicable, and results app or portal.

These are comparison questions, not a claim that every company offers the same package. FDA advises reading the instructions, understanding what a home test can and cannot do, and checking storage and expiration requirements. 4 The Simple 2 and Visby examples demonstrate why workflow and follow-up must be checked separately for each product. 2 3

The laboratory-credentials guide explains what a laboratory certificate can tell you. The privacy guide addresses records and app data.

What to do with the result

A positive finding needs appropriate medical follow-up rather than a self-selected treatment. An invalid result is not a negative result: follow the product's instructions or contact its clinical support service. FDA's authorizations describe follow-up and acknowledge that incorrect results remain possible. 2 3

A negative result may still leave an important question unresolved, particularly when symptoms, a recent exposure, or another concern remains. FDA specifically advises additional medical assessment in that situation for the Visby test. Testing timing should be discussed for the particular exposure and assay; a single waiting period cannot provide clearance for every infection. 1 2

Do not let the convenience of ordering a kit replace care you need now. CDC recommends discussing the appropriate testing with a healthcare provider, and the result should be interpreted alongside the reason you tested. 1 For continuing symptoms, see what negative vaginal tests do not settle.

The useful comparison

Choose a testing pathway that matches a defined question and provides a usable next step. A shorter panel that covers the right infection and site is more informative for that question than a larger panel that leaves them out. Keep the label, collection date, and complete result so that follow-up is based on what was actually tested, not simply “my home test was negative.” 1 4

This is general information, not an individual testing recommendation or diagnosis. See the medical information disclaimer.